Corbus Pharmaceuticals Holdings, Inc. (0SZI.L)
USD 14.17
(-0.14%)
USD 14.17
(-0.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -36.1 Million | -37.54 Million | -48.18 Million | -99.68 Million | -45.72 Million | -30.06 Million |
| Net Income | -44.6 Million | -42.34 Million | -45.64 Million | -111.26 Million | -71.45 Million | -55.67 Million |
| Depreciation & Amortization | 641 Thousand | 1.48 Million | 1.63 Million | 1.69 Million | 1.22 Million | 493.93 Thousand |
| Deferred income taxes | -1.02 Billion | - | 1.08 Million | 344.66 Thousand | - | 70.44 Thousand |
| Stock-based compensation | 3.47 Million | 5.71 Million | 9.48 Million | 12.45 Million | 11.98 Million | 7.6 Million |
| Change in working capital | 4.09 Million | -4.02 Million | -15.69 Million | -3.2 Million | 12.47 Million | 17 Million |
| Other non-cash items | 1.02 Billion | 1.61 Million | 950.61 Thousand | 291.39 Thousand | 45.83 Thousand | 422.33 Thousand |
| Investing Cash Flow | 35.64 Million | 30.07 Million | -73.41 Million | -484.49 Thousand | -2.74 Million | -2.3 Million |
| Investments in PPE | 3.00 | -13.44 Thousand | -54.17 Thousand | -484.49 Thousand | -2.74 Million | -2.3 Million |
| Acquisitions | - | 8100.00 | 23.9 Thousand | - | - | - |
| Investment purchases | -33.88 Million | -86.34 Million | -87.26 Million | - | - | - |
| Sales/Maturities of investments | 69.52 Million | 116.42 Million | 13.88 Million | - | - | - |
| Other Investing Activities | 35.64 Thousand | 30.08 Thousand | -73.36 Thousand | - | - | - |
| Financing Cash Flow | -2.82 Million | -533.61 Thousand | 60.82 Million | 154.87 Million | 38.46 Million | 11.41 Million |
| Debt repayment | -2.87 Million | -2.36 Million | -57.78 Thousand | -951.87 Thousand | -605.53 Thousand | -434.44 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 53.4 Thousand | - | 60.76 Million | 142.2 Million | 40.67 Million | 12.05 Million |
| Other Financing Activities | -2.00 | 1.83 Million | -1.82 Million | 13.62 Million | -1.6 Million | -198.55 Thousand |
| Accounts receivables | - | - | 1.61 Million | 1.06 Million | 5 Million | 12.5 Million |
| Accounts payables | 1.02 Million | -256.83 Thousand | -5.95 Million | -3.46 Million | 4.36 Million | 3.9 Million |
| Inventory | - | - | -1.61 Million | -1.06 Million | 9.57 Million | 5.39 Million |
| Other working capital | 3.06 Million | -3.76 Million | -9.74 Million | 264 Thousand | -6.46 Million | -4.78 Million |
| Cash at beginning of period | 17.19 Million | 25.67 Million | 86.45 Million | 31.74 Million | 41.74 Million | 62.69 Million |
| Cash at end of period | 13.91 Million | 17.67 Million | 25.67 Million | 86.45 Million | 31.74 Million | 41.74 Million |
| Capital Expenditure | 3.00 | -13.44 Thousand | -54.17 Thousand | -484.49 Thousand | -2.74 Million | -2.3 Million |
| Effect of forex changes on cash | -3.27 Billion | - | - | - | - | - |
| Net cash flow / Change in cash | -3.27 Million | -8 Million | -60.77 Million | 54.7 Million | -9.99 Million | -20.94 Million |
| Free Cash Flow | -36.1 Million | -37.55 Million | -48.23 Million | -100.17 Million | -48.46 Million | -32.36 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.99 Million | -6.89 Million | -44.6 Million | -8.02 Million | -10.05 Million | -8.78 Million |
| Depreciation & Amortization | 200 Thousand | 151.68 Thousand | 641 Thousand | 147.97 Thousand | 152.8 Thousand | 158.34 Thousand |
| Deferred income taxes | - | - | -1.02 Billion | -2.59 Million | -131.57 Thousand | -78.27 Thousand |
| Stock-based compensation | 1.28 Million | 982.01 Thousand | 3.47 Million | 799.17 Thousand | 821.22 Thousand | 823.37 Thousand |
| Change in working capital | 488.88 Thousand | -1.48 Million | 4.09 Million | 988.88 Thousand | 1.83 Million | -149.11 Thousand |
| Other non-cash items | 1.66 Million | 1.7 Million | 1.02 Billion | 2.67 Million | 203.64 Thousand | 229.24 Thousand |
| Investing Cash Flow | -16.43 Million | -98.23 Million | 35.64 Million | 10.38 Million | 10.89 Million | 8.8 Million |
| Investments in PPE | 2.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -24.82 Million | -105.89 Million | -33.88 Million | -3.32 Million | -6.62 Million | -10.62 Million |
| Sales/Maturities of investments | 8.38 Million | 7.66 Million | 69.52 Million | 13.71 Million | 17.52 Million | 19.42 Million |
| Other Investing Activities | -16.43 Thousand | -98.23 Thousand | 35.64 Thousand | 10.38 Thousand | 10.89 Thousand | 8807.49 |
| Financing Cash Flow | 34.96 Million | 106.58 Million | -2.82 Million | -1.9 Million | -820.5 Thousand | 17.68 Thousand |
| Debt repayment | -2.26 Million | -2.31 Million | -2.87 Million | -1.83 Million | -740.7 Thousand | -152.1 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 37.23 Million | 108.89 Million | 53.4 Thousand | -73.64 Thousand | 7537.00 | 199.51 Thousand |
| Other Financing Activities | 37.11 Thousand | -6.69 Million | -2.00 | -73.84 Thousand | -87.33 Thousand | -29.72 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -895.82 Thousand | -1.13 Million | 1.02 Million | -1.49 Million | 3.19 Million | 184.21 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.38 Million | -355.71 Thousand | 3.06 Million | 2.48 Million | -1.36 Million | -333.32 Thousand |
| Cash at beginning of period | 14.38 Million | 13.91 Million | 17.19 Million | 11.44 Million | 9.01 Million | 7.99 Million |
| Cash at end of period | 23.97 Million | 14.38 Million | 13.91 Million | 13.91 Million | 11.91 Million | 9.01 Million |
| Capital Expenditure | 2.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -3.27 Billion | 12.12 Million | -12.12 Million | - |
| Net cash flow / Change in cash | 9.58 Million | 471.91 Thousand | -3.27 Million | 2.47 Million | 2.89 Million | 1.02 Million |
| Free Cash Flow | -8.94 Million | -7.96 Million | -36.1 Million | -6 Million | -7.17 Million | -7.8 Million |
8WZ
3706
688633
0KGH
8515
MEDN